Ratio of the dose that causes Cardiovascular Collapse to the dose that causes CNS toxicity
A mixture of substances (in fixed proportions) that has a single melting point that is lower than the melting point of either constituent alone
The minimum concentration of a local anaesthetic at the nerve fibre that will block conduction of the action potential
Classification
Ester LAs
Amide LAs
Lipophilic end:
Hydrophilic end:
Intermediate chain:
Potency
Lipid Solubility
Protein Binding
Ionisation
Intrinsic vasodilator activity
Classification | Potency | Onset | Duration after Infiltration (min) | Maximum Single Dose for Infiltration (mg) | Toxic Plasma Concentration (μg/mL) | pK | Protein Binding (%) |
Esters | |||||||
Procaine | 1 | Slow | 45–60 | 500 | 8.9 | 6 | |
Chloroprocaine | 4 | Rapid | 30–45 | 600 | 8.7 | ||
Tetracaine | 16 | Slow | 60–180 | 100 (topical) | 8.5 | 76 | |
Amides | |||||||
Lidocaine | 1 | Rapid | 60–120 | 300 | > 5 | 7.9 | 70 |
Prilocaine | 1 | Slow | 60–120 | 400 | > 5 | 7.9 | 55 |
Mepivacaine | 1 | Slow | 90–180 | 300 | > 5 | 7.6 | 77 |
Bupivacaine | 4 | Slow | 240–480 | 175 | > 3 | 8.1 | 95 |
Levobupivacaine | 4 | Slow | 240–480 | 175 | 8.1 | > 97 | |
Ropivacaine | 4 | Slow | 240–480 | 200 | > 4 | 8.1 | 94 |
Classification | Fraction Nonionized (%) at pH 7.4 | Fraction Nonionized (%) at pH 7.6 | Lipid Solubility | Volume of Distribution (L) | Clearance (L/min) | Elimination Half-Time (min) |
Esters | ||||||
Procaine | 3 | 5 | 0.6 | 65 | 9 | |
Chloroprocaine | 5 | 7 | 35 | 7 | ||
Tetracaine | 7 | 11 | 80 | |||
Amides | ||||||
Lidocaine | 25 | 33 | 2.9 | 91 | 0.95 | 96 |
Prilocaine | 24 | 33 | 0.9 | 191 | 96 | |
Mepivacaine | 39 | 50 | 1 | 84 | 9.78 | 114 |
Bupivacaine | 17 | 24 | 28 | 73 | 0.47 | 210 |
Levobupivacaine | 17 | 24 | 55 | 156 | ||
Ropivacaine | 17 | 59 | 0.44 | 108 |
Absorption and Distribution
Absorption into systemic circulation depends on:
Plasma conc determined by:
Overall amide LAs are more widely distributed in tissues than ester LAs
Lung Extraction
Placental Transfer
Clearance
Esters
Amides
Metabolism
Amides
Esters
The onset of action will occur when concentration of LA at target nerve ≥ minimum effective concentration (Cm) (see section in Pharmacodynamics). The speed will be affected by
Drug Factors
Patient Factors
What's the deal with unionised fraction and lipid solubility?
A local anaesthetic will be effective at blocking nerve transmission while its concentration at the target nerve is ≥ minimum effective concentration (Cm) (see section in Pharmacodynamics). The offset of action is due to removal of LA from the site of action by vascular uptake, when LA conc falls below Cm. Duration of action is affected by:
Drug Factors
Patient Factors
Clinical Relevance
Structure and Function
Primary Mechanism
Secondary Mechanism
A Systemic
B Hypersensitivity
C Local Neurotoxicity
D Agent Specific
Dose-Dependent Systemic Effects of Lignocaine
Plasma Concentration (mcg/mL) | Effect |
---|---|
<1–5 | Analgesia |
5–10 | Numbness of tongue |
10–15 | Seizures Unconsciousness |
15–25 | Coma Respiratory arrest |
> 25 | Cardiovascular depression |
CC:CNS Ratio | |
---|---|
Lignocaine | 7 |
Bupivacaine | 3 |
Ropivacaine | 5 |
Why is bupivacaine toxicity worse than ropivacaine toxicity?
Local Anaesthetic | Max Dose (mg/kg) | Toxic Plasma Conc (ug/ml) |
---|---|---|
Lignocaine | 4 | > 5 |
Lignocaine w/ adr | 7 | |
Bupivacaine | 2 | > 1.5 |
Levo-bupivacaine | 2 | |
Ropivacaine | 3 | > 4 |
Sites of Action
Intrathecal Injection
Epidural Injection
Nerve Types Blocked
NB Both intrathecal and epidural blocks result in a segmental block, ie have both an upper and a lower limit, but because clinical issues arise much more commonly from the upper limit being too low than from the lower limit being too high, we tend to ignore the lower limit and only talk about the upper limit "block height"
Intrathecal Block
Drug/Technique Factors
Patient Factors
Epidural Block
Drug/Technique Factors
Patient Factors
Factor | Intrathecal Block | Epidural Block |
---|---|---|
Drug/Technique Factors | ||
Baricity/Positioning | +++ | + |
mg dose | +++ | |
Concentration | + | |
Volume | +++ | |
Patient Factors | ||
Height | (+) | (+) |
Obesity | (+) | (+) |
Pregnancy | + | + |
Drugs that affect LA pharmacokinetics
Drugs that affect LA pharmacodynamics (synergistic effect)
Peripheral BlocksEutectic Mixture
5% EMLA (Eutectic Mixture of Local Anaesthetics)
Transdermal Application
Adverse Effects
Why is EMLA an effective skin topical local anaesthetic, while 5% lignocaine is not?